Publications
56
Citations
2,302
Est. group size
—
Recurring co-author estimate
Active years
13
Publishing since 2014
Shriya Deshmukh's research focuses on how mutations in histone proteins (small proteins that package DNA) contribute to bone and soft-tissue tumors, particularly giant cell tumor of bone, by disrupting normal cell growth and differentiation through epigenetic mechanisms (chemical changes that control gene activity without altering DNA sequence). Recent work also extends into evaluating patient-derived tumor models, such as organoids and xenografts, as tools for predicting how cancers respond to treatment. The overall body of work sits at the intersection of cancer biology, epigenetics, and translational oncology.
Publication output has been variable over the past decade, with a notable spike in 2023 (likely reflecting a single multi-part dataset publication) and more modest, fluctuating activity in other years, averaging about 5 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs
Nature Genetics · 2026
- Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy
Cancer Treatment Reviews · 2026
- PP01.55: Early Clinical Activity of GT201, a mbIL-15–Engineered Tumor Infiltrating Lymphocyte Therapy in Relapsed EGFR-Mutated Metastatic NSCLC
Journal of Thoracic Oncology · 2026
- Patient-derived xenografts (PDX) versus patient-derived organoids (PDO) as predictors of clinical response to anti-cancer therapies.
Journal of Clinical Oncology · 2025
- Data from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Supplementary Figures from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S6 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S1 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S2 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S4 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Supplementary Data from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S3 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S5 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Supplementary Data from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Table S4 from H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone
2023
- Nature Genetics×3
- Cancer Research×3
- Nature Communications×2
- Cancer Cell×2
- Cancer Discovery×2
- Laura M. Warmke
Medicine · Indiana University
- Joel Mayerson
Medicine · The Ohio State University
- Joel L. Mayerson
Medicine · The Ohio State University
- Ira Miller
Medicine · The Ohio State University
- Hans Iwenofu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile